Journals Clinical and Experimental Immu...

Clinical and Experimental Immunology
Anna Lundgren, Susannah Leach, Hannes Axelsson, Pauline Isakson, Kristina Nyström, Lydia Scharf, Bengt A Andersson, Nicolae Miron, Emelie Marklund, Lars-Magnus Andersson, Magnus Gisslen, Davide Angeletti, Mats Bemark
Antigen-specific class-switched antibodies are detected at the same time or even before IgM in serum of non-vaccinated individuals infected with SARS-CoV-2. These derive from the first wave of plasmablasts formed. The phenotype and specificity of plasmablasts can reveal information about early B cell activation. Here we have analyzed B cells and plasmablasts circulating in blood of COVID-19 patients not previously exposed to SARS-CoV-2 during and after disease. We find that during infection with the original Wuhan strain, plasmablasts in blood produce IgA1, IgG1 and IgM, and that most express CCR10 and integrin β1, only some integrin β7, while the majority lack CCR9...
April 18, 2023: Clinical and Experimental Immunology
Sarah M Mahdally, Mariana Izquierdo, Rose M Viscardi, Laurence S Magder, Helena M Crowley, Andrea C Bafford, Cinthia B Drachenberg, Mauricio J Farfan, Alessio Fasano, Marcelo B Sztein, Rosangela Salerno-Goncalves
Previous work has shown that Secretory-IgA (SIgA) binding to the intestinal microbiota is variable and may regulate host inflammatory bowel responses. Nevertheless, the impact of the SIgA functional binding to the microbiota remains largely unknown in preterm infants whose immature epithelial barriers make them particularly susceptible to inflammation. Here, we investigated SIgA binding to intestinal microbiota isolated from stools of preterm infants <33 wk gestation with various levels of intestinal permeability...
April 18, 2023: Clinical and Experimental Immunology
N H R Litjens, A C J van der List, M Klepper, F Prevoo, K Boer, D A Hesselink, M G H Betjes
Acute T-cell mediated rejection (aTCMR) still remains a clinical problem after kidney transplantation despite significant improvements in immunosuppressive regimens. Polyfunctional T-cells, i.e. T-cells producing multiple pro-inflammatory cytokines, are believed to be the most relevant T-cells in an immune response. The aim of this study was to determine whether polyfunctional donor-reactive T-cells are associated with aTCMR. In a case-control study, 49 kidney transplant recipients with a biopsy-proven aTCMR in the first year after transplantation were included, as well as 51 controls without aTCMR...
April 18, 2023: Clinical and Experimental Immunology
Cindy S Ma, Stuart G Tangye
No abstract text is available yet for this article.
April 12, 2023: Clinical and Experimental Immunology
Hassan Sadozai, Vanessa Rojas-Luengas, Kaveh Farrokhi, Sajad Moshkelgosha, Qinli Guo, Wei He, Angela Li, Jianhua Zhang, Conan Chua, Dario Ferri, Muhtashim Mian, Oyedele Adeyi, Michael Seidman, Reginald M Gorczynski, Stephen Juvet, Harold Atkins, Gary A Levy, Andrzej Chruscinski
The ability to induce tolerance would be a major advance in the field of solid organ transplantation. Here, we investigated whether autologous (congenic) hematopoietic stem cell transplantation (HSCT) could promote tolerance to heart allografts in mice. In an acute rejection model, fully MHC-mismatched BALB/c hearts were heterotopically transplanted into C57BL/6 (CD45.2) mice. One week later, recipient mice were lethally irradiated and reconstituted with congenic B6 CD45.1 Lin -Sca1 +ckit + cells. Recipient mice received a 14-day course of rapamycin both to prevent rejection and to expand regulatory T cells (Tregs)...
April 2, 2023: Clinical and Experimental Immunology
Liqing Zhou, Haojie Wang, He Zhang, Fei Wang, Wenjing Wang, Qiong Cao, Zhihao Wei, Haitao Zhou, Shiyong Xin, Jianguo Zhang, Xiaofei Shi
Primary Sjögren's syndrome(pSS) is a chronic inflammatory autoimmune disease, which mainly damages patients' exocrine glands. Sensitive early diagnostic indicators and effective treatments for pSS are lacking. Using machine learning methods to find diagnostic markers and effective therapeutic ways for pSS is of great significance. In our study, first, 1643 differentially expressed genes (DEGs; 737 were upregulated and 906 were downregulated) were ultimately screened out and analyzed by Gene Ontology and Kyoto Encyclopedia of Genes and Genomes based on the date sets from the Gene Expression Omnibus...
March 29, 2023: Clinical and Experimental Immunology
Shu-Jung Hsu, Yen-Cheng Chao, Xia-Hui Lin, Hua-Hua Liu, Yang Zhang, Wei-Feng Hong, Mao-Pei Chen, Xin Xu, Lan Zhang, Zheng-Gang Ren, Shi-Suo Du, Rong-Xin Chen
Immune-related adverse events (irAEs) clinically resemble autoimmune diseases, indicating autoantibodies could be potential biomarkers for the prediction of irAEs. This study aimed to assess the predictive value of peripheral blood antinuclear antibody (ANA) status for irAEs, considering the time and severity of irAEs, as well as treatment outcome in liver cancer patients administered anti-PD-1 therapy. Ninety-three patients with advanced primary liver cancer administered anti-PD-1 treatment were analyzed retrospectively...
March 26, 2023: Clinical and Experimental Immunology
Laleh Pezhman, Sophie J Hopkin, Jenefa Begum, Silke Heising, Daniela Nasteska, Mussarat Wahid, G Ed Rainger, David J Hodson, Asif J Iqbal, Myriam Chimen, Helen M McGettrick
Dysregulation of leukocyte trafficking, lipid metabolism, and other metabolic processes are the hallmarks that underpin and drive pathology in obesity. Current clinical management targets alternations in lifestyle choices (e.g. exercise, weight loss) to limit the impact of the disease. Crucially, re-gaining control over the pathogenic cellular and molecular processes may offer an alternative, complementary strategy for obese patients. Here we investigate the impact of the immunopeptide, PEPITEM, on pancreas homeostasis and leukocyte trafficking in mice on high-fed obesogenic diet (HFD)...
April 7, 2023: Clinical and Experimental Immunology
Elvira Favoino, Ettore Grapsi, Giovanna Barbuti, Vasiliki Liakouli, Piero Ruscitti, Caterina Foti, Roberto Giacomelli, Federico Perosa
Anti-centromere (ACA) and antimitochondrial antibodies (AMA) are specific for limited-cutaneous systemic sclerosis (lcSSc) and primary biliary cholangitis (PBC), respectively, and can coexist in up to 25 and 30% of SSc and PBC patients. Here, we evaluated whether anti-centromeric protein A (CENP-A) antibodies cross-react with mitochondrial antigens. To this end, sera from two lcSSc patients (pt1 and pt4), one of them (pt4) also affected by PBC, were used as the source of ACA, previously shown to recognize different groups of amino acids (motifs) in the CENP-A region spanning amino acids 1-17 (Ap1-17)...
April 7, 2023: Clinical and Experimental Immunology
Christian Schütz, Xenofon Baraliakos
Ankylosing Spondylitis is the main entity of a family of inflammatory diseases affecting many musculoskeletal (sacroiliac joints, spine, peripheral joints) and extra-musculoskeletal sites, termed spondyloarthritis. While it is debated whether disease onset is primarily driven by autoimmune or autoinflammatory processes, what is certain is that both innate and adaptive immune responses orchestrate local and systemic inflammation, which leads to chronic pain and immobility. Immune checkpoint signals are one key player for keeping the immune system in check and in balance, but their role in disease pathogenesis is still rather elusive...
March 8, 2023: Clinical and Experimental Immunology
Isa Seida, Mahmoud Alrais, Ravend Seida, Abdulkarim Alwani, Zeynep Kiyak, Abdulrahman Elsalti, Sevval Nil Esirgun, Tunahan Abali, Naim Mahroum
Adjuvants, as the name indicates, are adjoined material aimed to assist in functioning as when added to vaccines they are meant to boost the effect and strongly stimulate the immune system. The response of the immune system can be unpredictable, and the autoimmune/inflammatory syndrome induced by adjuvants (ASIA) was developed to address possible adverse reactions of an autoimmune and inflammatory type that may be caused by adjuvants. While ASIA, as a syndrome, was coined and defined in 2011; reports describing patients with vague and nonspecific clinical symptoms following vaccinations appeared much earlier...
March 7, 2023: Clinical and Experimental Immunology
Scott Fiala, Howard B Fleit
Allergen immunotherapy (AIT) is currently the only form of treatment that modifies allergic asthma. Pharmacotherapy alone seeks to control the symptoms of allergic asthma, allergic rhinitis, and other atopic conditions. In contrast, AIT can induce long-term physiological modifications through the immune system. AIT enables individuals to live improved lives many years after treatment ends, where they are desensitized to the allergen(s) used or no longer have significant allergic reactions upon allergen provocation...
March 5, 2023: Clinical and Experimental Immunology
Shoumit Dey, Helen Ashwin, Luke Milross, Bethany Hunter, Joaquim Majo, Andrew J Filby, Andrew J Fisher, Paul M Kaye, Dimitris Lagos
T cells play key protective but also pathogenic roles in COVID-19. We studied expression of long non-coding RNAs (lncRNAs) in COVID-19 T cell transcriptomes by integrating previously published single-cell RNA sequencing datasets. The long intergenic non-coding RNA MALAT1 was the most highly transcribed lncRNA in T cells, with Th1 cells demonstrating the lowest and CD8+ resident memory cells the highest MALAT1 expression, amongst CD4+ and CD8+ T cells populations, respectively. We then identified gene signatures that covaried with MALAT1 in single T cells...
March 3, 2023: Clinical and Experimental Immunology
Xin Huang, Lukanxuan Wu, Tianjiao Pei, Dong Liu, Chang Liu, Bin Luo, Li Xiao, Yujing Li, Ruiying Wang, Yunwei Ouyang, Huili Zhu, Wei Huang
Endometriosis is a common inflammatory disorder in women of reproductive age due to an abnormal endometrial immune environment and is associated with infertility. This study aimed to systematically understand the endometrial leukocyte types, inflammatory environment, and impaired receptivity at single-cell resolution. We profiled single-cell RNA transcriptomes of 138,057 endometrial cells from endometriosis patients (n=6) and control (n=7), respectively, using 10x Genomics platform. We found that one cluster of epithelial cells that expressed PAEP and CXCL14 was mostly from the control during the window of implantation (WOI)...
March 3, 2023: Clinical and Experimental Immunology
Yun Yan Foo, Angelina Tiah, Shuh Wen Aung
Natural killer (NK) cells possess the innate ability to eliminate cancerous cells effectively. Their crucial role in immunosurveillance has been widely recognised and exploited for therapeutic intervention. Despite the fast-acting nature of NK cells, NK adoptive cell transfer lacks favourable response in some patients. Patient NK cells often display diminished phenotype in preventing cancer progression resulting in poor prognosis. Tumour microenvironment play a significant role in causing the downfall of NK cells in patients...
March 2, 2023: Clinical and Experimental Immunology
Mélissa Noack, Pierre Miossec
Cell interactions represent an important mechanism involved in the pathogenesis of chronic inflammation. The key S100 proteins A8 and A9 have been studied in several models of chronic inflammatory diseases with highly heterogeneous conclusions. In this context, the aim of this study was to determine the role of cell interactions on S100 protein production and their effect on cytokine production during cell interactions, between immune and stromal cells from synovium or skin. Peripheral blood mononuclear cells (PBMC) were cultured alone or with synoviocytes or skin fibroblasts, with or without phytohemagglutinin, exogenous A8, A9, A8/A9 proteins or anti-A8/A9 antibody...
March 2, 2023: Clinical and Experimental Immunology
Yawen Lin, Xiaofeng Zhu, Yiwen Li, Yue Dou, Jing Wang, Ruiqun Qi, Lei Ma
(IL)-17A, the effective factor of Th17 cells acts on important pathological role in the pathogenesis of psoriasis. Notch1/hairy and split 1 (Hes1) and PI3K/AKT signaling pathways are interpenetrated and involved in Th17 cell differentiation and IL-17A production. In this present study, we used imiquimod (IMQ)-induced mouse psoriatic skin inflammation to explore the possible mechanism of Notch1/Hes1-PTEN/AKT/IL-17A feedback loop in psoriasis by employing AKT inhibitor LY294002 as an intervention with the methods of flow cytometry analysis, reverse transcription-quantitative polymerase chain reaction, western blot, co-immunoprecipitation and immunofluorescence...
February 25, 2023: Clinical and Experimental Immunology
Sylvain Beaumel, Lucile Verbrugge, Franck Fieschi, Marie José Stasia
Chronic Granulomatous Disease (CGD) is a rare primary immune disorder caused by mutations in one of the five subunits of the NADPH oxidase complex expressed in phagocytes. Two-thirds of CGD cases are caused by mutations in CYBB that encodes NOX2 or gp91 phox. Some rare X91 +-CGD point mutations lead to a loss-of-function but with a normal expression of the mutated NOX2 protein. It is therefore necessary to ensure that this mutation is indeed responsible for the loss of activity in order to make a safe diagnosis for genetic counselling...
February 24, 2023: Clinical and Experimental Immunology
Síle A Johnson, Eloise Phillips, Sandra Adele, Stephanie Longet, Tom Malone, Chris Mason, Lizzie Stafford, Anni Jamsen, Siobhan Gardiner, Alexandra Deeks, Janice Neo, Emily J Blurton, Jemima White, Muhammed Ali, Barbara Kronsteiner, Joseph D Wilson, Dónal T Skelly, Katie Jeffery, Christopher P Conlon, Philip Goulder, Miles Carroll, Eleanor Barnes, Paul Klenerman, Susanna J Dunachie
T cells are important in preventing severe disease from SARS-CoV-2, but scalable and field-adaptable alternatives to expert T cell assays are needed. The interferon-gamma release assay QuantiFERON platform was developed to detect T cell responses to SARS-CoV-2 from whole blood with relatively basic equipment and flexibility of processing timelines. 48 participants with different infection and vaccination backgrounds were recruited. Whole blood samples were analysed using the QuantiFERON SARS-CoV-2 assay in parallel with the well-established 'Protective Immunity from T Cells in Healthcare workers' (PITCH) ELISpot, which can evaluate spike-specific T cell responses...
February 21, 2023: Clinical and Experimental Immunology
Sofie Albinsson, Christine Lingblom, Leif Johansson, Helen Larsson, Christine Wennerås
Eosinophilic esophagitis is a T cell-driven allergic condition hallmarked by eosinophil infiltration of the esophagus. Eosinophils exposed to proliferating T cells release galectin-10 and have T cell suppressive function in vitro. The aims of this study were to evaluate if eosinophils co-localize with T cells and release galectin-10 in the esophagus of patients with eosinophilic esophagitis. Esophageal biopsies from 20 patients with eosinophilic esophagitis were stained for major basic protein, galectin-10, CD4, CD8, CD16, and CD81 and analyzed by immunofluorescence confocal microscopy before and after topical corticosteroid treatment...
February 20, 2023: Clinical and Experimental Immunology
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.